Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New XFe96 Spheroid Microplate from Seahorse Bioscience
Tuesday, April 22, 2014
The microplate enables functional, metabolic measurement of in vitro tumor spheroids.

Leica Microsystems Celebrates 10 Years of Super-Resolution Innovations
Wednesday, April 16, 2014
Leica TCS SP8 STED 3X introduction in 2014 marks Company’s 10th anniversary.

Analytik Announces the Availability of VideometerLab 3
Wednesday, April 16, 2014
Latest multi-spectral imaging system now available in the UK and Ireland.

Efficient Delivery of Proteins into Living Cells
Tuesday, April 15, 2014
BioPORTER® protein delivery reagent from AMSBIO.

InSphero to Distribute Dainippon Screen Imager for Rapid Profiling of 3D Microtissues
Tuesday, April 08, 2014
The Cell'iMager, to be marketed in the US and Europe, simplifies growth and morphological profiling of 3D microtissues.

New Application of TAP’s Automated Cell Culture System at AACR
Saturday, April 05, 2014
Offers rapid production and consistent quality of NCI 60 cancer cell line panel.

Physiologically Relevant Cell Culture Handbook
Tuesday, April 01, 2014
48-page handbook is also a resource for neuroscience, drug discovery and regenerative medicine applications.

Eppendorf Named as Official Sponsor of Amateur Photography Competition
Thursday, March 27, 2014
Home, habitat & shelter 2014 photography competition by the Society of Biology.

Hepregen Launches First Human HepatoPac™ Assay Kit
Wednesday, March 26, 2014
Application-directed kit provides information useful in predicting potential drug-induced liver injury.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 220
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv